Nestlé Health Science publishes data showing weight loss and cardiovascular risk reduction with Optifast® meal replacement streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Codexis (CDXS) and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Enterome and Nestlé Health Science will co-develop Enterome's lead EndoMimics compound, EB1010, a potent local inducer of IL-10 targeting food allergies and inflammatory bowel disease (IBD).